Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therap...

ver descrição completa

Detalhes bibliográficos
Autores: Burroughs, Andrew K., Groszmann, Roberto J., Bosch i Genover, Jaume, Grace, N. D., Garcia-Tsao, G., Patch, D., García Pagán, Juan Carlos, Dagher, L.
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2002
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositório:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/18650
Acesso em linha:https://hdl.handle.net/2445/18650
Access Level:Acceso aberto
Palavra-chave:Hepatitis C
Virosi (Peixos)
Pressió venosa
Virus diseases (Fishes)
Venous pressure
id ES_14405707e14d0a2e484322dfbbfbda4b
oai_identifier_str oai:recercat.cat:2445/18650
network_acronym_str ES
network_name_str España
repository_id_str
spelling Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?Burroughs, Andrew K.Groszmann, Roberto J.Bosch i Genover, JaumeGrace, N. D.Garcia-Tsao, G.Patch, D.García Pagán, Juan CarlosDagher, L.Hepatitis CVirosi (Peixos)Pressió venosaHepatitis CVirus diseases (Fishes)Venous pressureChronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therapeutic evaluation of antiviral therapy in chronic hepatitis C. It is a validated technique which is safe, well tolerated, well established, and reproducible. Serial HVPG measurements may be the best way to evaluate response to therapy in chronic hepatitis C.BMJ Group201120112002info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion3 p.application/pdfhttps://hdl.handle.net/2445/18650Articles publicats en revistes (Medicina)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.50.3.425Gut, 2002, vol. 50, núm. 3, p. 425-427http://dx.doi.org/10.1136/gut.50.3.425(c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002info:eu-repo/semantics/openAccessoai:recercat.cat:2445/186502026-05-29T05:05:01Z
dc.title.none.fl_str_mv Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
title Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
spellingShingle Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Burroughs, Andrew K.
Hepatitis C
Virosi (Peixos)
Pressió venosa
Hepatitis C
Virus diseases (Fishes)
Venous pressure
title_short Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
title_full Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
title_fullStr Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
title_full_unstemmed Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
title_sort Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
dc.creator.none.fl_str_mv Burroughs, Andrew K.
Groszmann, Roberto J.
Bosch i Genover, Jaume
Grace, N. D.
Garcia-Tsao, G.
Patch, D.
García Pagán, Juan Carlos
Dagher, L.
author Burroughs, Andrew K.
author_facet Burroughs, Andrew K.
Groszmann, Roberto J.
Bosch i Genover, Jaume
Grace, N. D.
Garcia-Tsao, G.
Patch, D.
García Pagán, Juan Carlos
Dagher, L.
author_role author
author2 Groszmann, Roberto J.
Bosch i Genover, Jaume
Grace, N. D.
Garcia-Tsao, G.
Patch, D.
García Pagán, Juan Carlos
Dagher, L.
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Hepatitis C
Virosi (Peixos)
Pressió venosa
Hepatitis C
Virus diseases (Fishes)
Venous pressure
topic Hepatitis C
Virosi (Peixos)
Pressió venosa
Hepatitis C
Virus diseases (Fishes)
Venous pressure
description Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therapeutic evaluation of antiviral therapy in chronic hepatitis C. It is a validated technique which is safe, well tolerated, well established, and reproducible. Serial HVPG measurements may be the best way to evaluate response to therapy in chronic hepatitis C.
publishDate 2002
dc.date.none.fl_str_mv 2002
2011
2011
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/18650
url https://hdl.handle.net/2445/18650
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.50.3.425
Gut, 2002, vol. 50, núm. 3, p. 425-427
http://dx.doi.org/10.1136/gut.50.3.425
dc.rights.none.fl_str_mv (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 3 p.
application/pdf
dc.publisher.none.fl_str_mv BMJ Group
publisher.none.fl_str_mv BMJ Group
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403725957693440
score 15.812429

Registros relacionados